Clinical trial
Treatment of Pneumocystis in COPD (the TOPIC Study)
NCT05418777 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Pneumocystis in COPD (the TOPIC Study)
- Lead sponsor
- Corewell Health East
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- September 28, 2022
- Completion date
- December 19, 2022
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd exacerbation acute